[96a5a0]: / output / allTrials / identified / NCT00884273_identified.json

Download this file

514 lines (514 with data), 20.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
{
"info": {
"nct_id": "NCT00884273",
"official_title": "A Randomised, Parallel-arm, Open-label Trial Comparing Degarelix With Goserelin Plus Anti-androgen Flare Protection (Bicalutamide), in Terms of Volume Reduction of the Prostate in Patients With Prostate Cancer Being Candidates for Medical Castration",
"inclusion_criteria": "1. Patient has given written informed consent\n2. Patient is 18 years or older\n3. Patient has histologically confirmed prostate cancer\n4. Patient has a serum prostate-specific antigen (PSA) level at screening >2 ng/mL\n5. The prostate size is >30 cubic centimetres (cc), measured by TRUS\n6. Patient has had a bone-scan within 12 weeks before inclusion\n7. Patient must be able to undergo transrectal examinations\n8. Patient has an estimated life expectancy of at least 12 months\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "1. Any previous treatments for prostate cancer\n2. Previous trans-urethral resection of the prostate (TURP)\n3. Is not considered a candidate for medical castration\n4. Use of urethral catheter\n5. Is currently treated with a 5-alpha reductase inhibitor\n6. Is currently treated with an alpha-adrenoceptor antagonist\n7. Treatment with botulinum toxin A (Botox)\n8. Require radiotherapy during the trial\n9. History of severe untreated asthma, anaphylactic reactions, or severe urticaria and/or angioedema\n10. Hypersensitivity towards any component of the investigational products or excipients\n11. Previous history or presence of another malignancy\n12. A clinically significant disorder\n13. A corrected QT interval over 450 msec\n14. Mental incapacity or language barrier precluding adequate understanding or co-operation\n15. Receipt of an investigational drug within the last 28 days proceeding screening\n16. Previous participation in any degarelix trial",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. Patient has given written informed consent",
"criterions": [
{
"exact_snippets": "Patient has given written informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "2. Patient is 18 years or older",
"criterions": [
{
"exact_snippets": "Patient is 18 years or older",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "3. Patient has histologically confirmed prostate cancer",
"criterions": [
{
"exact_snippets": "histologically confirmed prostate cancer",
"criterion": "prostate cancer",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": "histologically confirmed"
}
]
}
]
},
{
"line": "4. Patient has a serum prostate-specific antigen (PSA) level at screening >2 ng/mL",
"criterions": [
{
"exact_snippets": "serum prostate-specific antigen (PSA) level at screening >2 ng/mL",
"criterion": "serum prostate-specific antigen (PSA) level",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "ng/mL"
}
}
]
}
]
},
{
"line": "5. The prostate size is >30 cubic centimetres (cc), measured by TRUS",
"criterions": [
{
"exact_snippets": "The prostate size is >30 cubic centimetres (cc)",
"criterion": "prostate size",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 30,
"unit": "cubic centimetres (cc)"
}
}
]
}
]
},
{
"line": "6. Patient has had a bone-scan within 12 weeks before inclusion",
"criterions": [
{
"exact_snippets": "Patient has had a bone-scan within 12 weeks before inclusion",
"criterion": "bone-scan",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "within 12 weeks before inclusion"
}
]
}
]
},
{
"line": "7. Patient must be able to undergo transrectal examinations",
"criterions": [
{
"exact_snippets": "Patient must be able to undergo transrectal examinations",
"criterion": "ability to undergo transrectal examinations",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "8. Patient has an estimated life expectancy of at least 12 months",
"criterions": [
{
"exact_snippets": "estimated life expectancy of at least 12 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 12,
"unit": "months"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Any previous treatments for prostate cancer",
"criterions": [
{
"exact_snippets": "previous treatments for prostate cancer",
"criterion": "previous treatments for prostate cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "2. Previous trans-urethral resection of the prostate (TURP)",
"criterions": [
{
"exact_snippets": "Previous trans-urethral resection of the prostate (TURP)",
"criterion": "trans-urethral resection of the prostate (TURP)",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "3. Is not considered a candidate for medical castration",
"criterions": [
{
"exact_snippets": "Is not considered a candidate for medical castration",
"criterion": "candidate for medical castration",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
}
]
},
{
"line": "4. Use of urethral catheter",
"criterions": [
{
"exact_snippets": "Use of urethral catheter",
"criterion": "urethral catheter",
"requirements": [
{
"requirement_type": "use",
"expected_value": true
}
]
}
]
},
{
"line": "5. Is currently treated with a 5-alpha reductase inhibitor",
"criterions": [
{
"exact_snippets": "currently treated with a 5-alpha reductase inhibitor",
"criterion": "5-alpha reductase inhibitor treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "6. Is currently treated with an alpha-adrenoceptor antagonist",
"criterions": [
{
"exact_snippets": "currently treated with an alpha-adrenoceptor antagonist",
"criterion": "alpha-adrenoceptor antagonist treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "7. Treatment with botulinum toxin A (Botox)",
"criterions": [
{
"exact_snippets": "Treatment with botulinum toxin A (Botox)",
"criterion": "botulinum toxin A (Botox) treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "8. Require radiotherapy during the trial",
"criterions": [
{
"exact_snippets": "Require radiotherapy during the trial",
"criterion": "radiotherapy",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "9. History of severe untreated asthma, anaphylactic reactions, or severe urticaria and/or angioedema",
"criterions": [
{
"exact_snippets": "History of severe untreated asthma",
"criterion": "asthma",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "treatment status",
"expected_value": "untreated"
}
]
},
{
"exact_snippets": "anaphylactic reactions",
"criterion": "anaphylactic reactions",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "severe urticaria",
"criterion": "urticaria",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
}
]
},
{
"exact_snippets": "angioedema",
"criterion": "angioedema",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "10. Hypersensitivity towards any component of the investigational products or excipients",
"criterions": [
{
"exact_snippets": "Hypersensitivity towards any component of the investigational products",
"criterion": "hypersensitivity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Hypersensitivity towards any component of the ... excipients",
"criterion": "hypersensitivity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "11. Previous history or presence of another malignancy",
"criterions": [
{
"exact_snippets": "Previous history ... of another malignancy",
"criterion": "history of another malignancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "presence of another malignancy",
"criterion": "presence of another malignancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "12. A clinically significant disorder",
"criterions": [
{
"exact_snippets": "clinically significant disorder",
"criterion": "disorder",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
}
]
},
{
"line": "13. A corrected QT interval over 450 msec",
"criterions": [
{
"exact_snippets": "corrected QT interval over 450 msec",
"criterion": "corrected QT interval",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 450,
"unit": "msec"
}
}
]
}
]
},
{
"line": "14. Mental incapacity or language barrier precluding adequate understanding or co-operation",
"criterions": [
{
"exact_snippets": "Mental incapacity",
"criterion": "mental capacity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "language barrier",
"criterion": "language barrier",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "15. Receipt of an investigational drug within the last 28 days proceeding screening",
"criterions": [
{
"exact_snippets": "Receipt of an investigational drug within the last 28 days",
"criterion": "investigational drug receipt",
"requirements": [
{
"requirement_type": "time since last receipt",
"expected_value": {
"operator": "<=",
"value": 28,
"unit": "days"
}
}
]
}
]
},
{
"line": "16. Previous participation in any degarelix trial",
"criterions": [
{
"exact_snippets": "Previous participation in any degarelix trial",
"criterion": "previous participation in degarelix trial",
"requirements": [
{
"requirement_type": "participation",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}